Search Results 431-440 of 17232 for GLP-1 medication

  1. A Study to assess the Safety of NRL-1 for the Treatment of People with Epilepsy - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  2. Glucosamine - Mayo Clinic

    Taking glucosamine sulfate and acetaminophen together might reduce the effectiveness of both the supplement and medication. ... Address 1. ErrorEmail field is ...

  3. Guanadrel (oral route) - Side effects & dosage - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  4. Drospirenone, ethinyl estradiol, and levomefolate (oral route) - Side effects & dosage - Mayo Clinic

    Your doctor may decide not to treat you with this medication or change some of the other medicines you take. ... This means that you may take 2 pills in 1 day.

  5. Paclitaxel protein-bound (intravenous route) - Mayo Clinic

    ... medicine or any other medicines. ... Your doctor may decide not to treat you with this medication or change some of the other medicines you take. ... 1-800-FDA-1088 ...

  6. Latent autoimmune diabetes in adults (LADA): What is it? - Mayo Clinic

    Instead, they see it as the same disease, type 1 diabetes, that happens differently in adults than it does in children. ... treatment is still the best one for ...

  7. Gallium ga 68 psma-11 (intravenous route) - Side effects & uses - Mayo Clinic

    ... 1 hour after the PET scan. Back to top. Precautions. It is very important that your doctor check you closely while you are receiving this medicine. This will ...

  8. Antidepressants: Safe during pregnancy? - Mayo Clinic

    Medicines often are important for treating ... Taking medicines during pregnancy has risks and benefits. ... Click here for an email preview. Email. Address 1.

  9. Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    ... glucagon-like peptide (GLP)- 1 agonists, or insulin. Dose changes of these medications are allowed in the 6 months prior to diagnostic liver biopsy, except for ...

  10. Infliximab (intravenous route) - Mayo Clinic

    ... medicine or any other medicines. Also ... This medicine should come with a Medication Guide. ... You may report side effects to the FDA at 1-800-FDA-1088.